These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3989142)

  • 1. Polyethylene glycol-modified ragweed pollen extract in rhinoconjunctivitis.
    Juniper EF; Roberts RS; Kennedy LK; O'Connor J; Syty-Golda M; Dolovich J; Hargreave FE
    J Allergy Clin Immunol; 1985 May; 75(5):578-85. PubMed ID: 3989142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyethylene glycol-modified ragweed extract: comparison of two treatment regimens.
    Juniper EF; O'Connor J; Roberts RS; Evans S; Hargreave FE; Dolovich J
    J Allergy Clin Immunol; 1986 Nov; 78(5 Pt 1):851-6. PubMed ID: 3782653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seasonal changes in IgE antibodies and their relationship to IgG antibodies during immunotherapy for ragweed hay fever.
    Yunginger JW; Gleich GJ
    J Clin Invest; 1973 May; 52(5):1268-75. PubMed ID: 4735589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A controlled study of the effectiveness of the Rinkel method of immunotherapy for ragweed pollen hay fever.
    Van Metre TE; Adkinson NF; Lichtenstein LM; Mardiney MR; Norman PS; Rosenberg GL; Sobotka AK; Valentine MD
    J Allergy Clin Immunol; 1980 Apr; 65(4):288-97. PubMed ID: 6987291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sublingual immunotherapy in patients with allergic rhinoconjunctivitis caused by ragweed pollen.
    Skoner D; Gentile D; Bush R; Fasano MB; McLaughlin A; Esch RE
    J Allergy Clin Immunol; 2010 Mar; 125(3):660-6, 666.e1-666.e4. PubMed ID: 20153030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allergic rhinitis to ragweed pollen. II. Modulation of histamine-releasing factor production by specific immunotherapy.
    Brunet C; Bédard PM; Lavoie A; Jobin M; Hébert J
    J Allergy Clin Immunol; 1992 Jan; 89(1 Pt 1):87-94. PubMed ID: 1370511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic effects of encapsulated short ragweed extract: a potent new agent for oral immunotherapy.
    Litwin A; Flanagan M; Entis G; Gottschlich G; Esch R; Gartside P; Michael JG
    Ann Allergy Asthma Immunol; 1996 Aug; 77(2):132-8. PubMed ID: 8760779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of a short course of specific immunotherapy in patients with allergic rhinoconjunctivitis to ragweed pollen.
    Patel P; Holdich T; Fischer von Weikersthal-Drachenberg KJ; Huber B
    J Allergy Clin Immunol; 2014 Jan; 133(1):121-9.e1-2. PubMed ID: 23870670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of immunotherapy schedules for injection treatment of ragweed pollen hay fever.
    Van Metre TE; Adkinson NF; Amodio FJ; Kagey-Sobotka A; Lichtenstein LM; Mardiney MR; Norman PS; Rosenberg GL
    J Allergy Clin Immunol; 1982 Feb; 69(2):181-93. PubMed ID: 7056949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis.
    Creticos PS; Schroeder JT; Hamilton RG; Balcer-Whaley SL; Khattignavong AP; Lindblad R; Li H; Coffman R; Seyfert V; Eiden JJ; Broide D;
    N Engl J Med; 2006 Oct; 355(14):1445-55. PubMed ID: 17021320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic effect and tolerability of intra-seasonal subcutaneous immunotherapy with an 8-day up-dosing schedule to 10,000 standardized quality-units: a double-blind, randomized, placebo-controlled trial.
    Pfaar O; Wolf H; Klimek L; Schnitker J; Wüstenberg E
    Clin Ther; 2012 Oct; 34(10):2072-81. PubMed ID: 23063373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled evaluation of allergoid in the immunotherapy of ragweed hay fever.
    Norman PS; Lichtenstein LM; Kagey-Sobotka A; Marsh DG
    J Allergy Clin Immunol; 1982 Oct; 70(4):248-60. PubMed ID: 6181113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind study of the discontinuation of ragweed immunotherapy.
    Naclerio RM; Proud D; Moylan B; Balcer S; Freidhoff L; Kagey-Sobotka A; Lichtenstein LM; Creticos PS; Hamilton RG; Norman PS
    J Allergy Clin Immunol; 1997 Sep; 100(3):293-300. PubMed ID: 9314339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative safety and efficacy of short ragweed extracts differing in potency and composition in the treatment of fall hay fever. Use of allergenically bioequivalent doses by parallel line bioassay to evaluate comparative safety and efficacy.
    Turkeltaub PC; Campbell G; Mosimann JE
    Allergy; 1990 Oct; 45(7):528-46. PubMed ID: 2252164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the in-vivo and in-vitro response to ragweed immunotherapy in children and adults with ragweed-induced rhinitis.
    Hedlin G; Silber G; Naclerio R; Proud D; Lamas AM; Eggleston P; Adkinson NF
    Clin Exp Allergy; 1990 Sep; 20(5):491-500. PubMed ID: 2253080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.
    Reich K; Gessner C; Kroker A; Schwab JA; Pohl W; Villesen H; Wüstenberg E; Emminger W
    Clin Ther; 2011 Jul; 33(7):828-40. PubMed ID: 21741092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical and immunologic efficacy of immunotherapy with modified ragweed extract (allergoid) for ragweed hay fever.
    Meriney DK; Kothari H; Chinoy P; Grieco MH
    Ann Allergy; 1986 Jan; 56(1):34-8. PubMed ID: 2418713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgE antibody measurements in ragweed hay fever. Relationship to clinical severity and the results of immunotherapy.
    Lichtenstein LM; Ishizaka K; Norman PS; Sobotka AK; Hill BM
    J Clin Invest; 1973 Feb; 52(2):472-82. PubMed ID: 4119162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allergic rhinitis to ragweed pollen. I. Reassessment of the effects of immunotherapy on cellular and humoral responses.
    Brunet C; Bédard PM; Lavoie A; Jobin M; Hébert J
    J Allergy Clin Immunol; 1992 Jan; 89(1 Pt 1):76-86. PubMed ID: 1370510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study.
    Bufe A; Ziegler-Kirbach E; Stoeckmann E; Heidemann P; Gehlhar K; Holland-Letz T; Braun W
    Allergy; 2004 May; 59(5):498-504. PubMed ID: 15080830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.